Obiltoxaximab

Therapeutic indications

Obiltoxaximab is indicated for:

Inhalational anthrax

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Obiltoxaximab is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to Bacillus anthracis.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

16 mg/kg body weight once for patients weighing ≥40 kg and 24 mg/kg body weight once for patients weighing <40 kg

16 mg/kg/bw once for patients weighting ≥40 kg, 24 mg/kg/bw once for patients weighting 15-40 kg, 32 mg/kg/bw once for patients weighting ≤15 kg

Inhalational anthrax

Population group: only minors (0 - 18 years old) , adults (18 years old or older)

Obiltoxaximab is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

16 mg/kg body weight once for patients weighing ≥40 kg and 24 mg/kg body weight once for patients weighing <40 kg

16 mg/kg/bw once for patients weighting ≥40 kg, 24 mg/kg/bw once for patients weighting 15-40 kg, 32 mg/kg/bw once for patients weighting ≤15 kg

Contraindications

Obiltoxaximab is contraindicated in the following cases:

Pregnancy

< Previous: Overview

Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

Obiltoxaximab

Therapeutic indications

Inhalational anthrax

16 mg/kg body weight once for patients weighing ≥40 kg and 24 mg/kg body weight once for patients weighing <40 kg

16 mg/kg/bw once for patients weighting ≥40 kg, 24 mg/kg/bw once for patients weighting 15-40 kg, 32 mg/kg/bw once for patients weighting ≤15 kg

Inhalational anthrax

16 mg/kg body weight once for patients weighing ≥40 kg and 24 mg/kg body weight once for patients weighing <40 kg

16 mg/kg/bw once for patients weighting ≥40 kg, 24 mg/kg/bw once for patients weighting 15-40 kg, 32 mg/kg/bw once for patients weighting ≤15 kg

Contraindications

Pregnancy

Get recommendations

Related medicines